AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (November 19, 2008). doi:10.1152/ajprenal.90543.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/2/F382    most recent
90543.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S. M.
Right arrow Articles by Schnermann, J. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S. M.
Right arrow Articles by Schnermann, J. B
Submitted on September 15, 2008
Revised on November 4, 2008
Accepted on November 13, 2008

Dense Core Vesicle Proteins IA-2 and IA-2{beta} affect Renin Synthesis and Secretion through the {beta}-Adrenergic Pathway

Soo Mi Kim1, Franziska Theilig2, Yan Qin1, Tao Cai1, Diane Mizel, Robert Faulhaber-Walter1, Hiroki Hirai1, Sebastian Bachmann3, Josephine P Briggs1, Abner L Notkins1, and Jurgen B Schnermann4*

1 NIH
2 Charite - Universitatsmedizin Berlin
3 Charit Berlin
4 NIDDK, NIH

* To whom correspondence should be addressed. E-mail: jurgens{at}intra.niddk.nih.gov.

IA-2 and IA-2{beta}, major autoantigens in type 1 diabetes, are transmembrane proteins in dense core vesicles and their expression influences the secretion of hormones and neurotransmitters. The present experiments were performed to examine whether IA-2 and IA-2{beta} modulate the release of renin from dense core vesicles of juxtaglomerular granular cells in the kidney. Plasma renin concentration (PRC; ng angiotensin I/ml hr) was significantly reduced in mice with null mutations in IA-2, IA-2{beta}, or both IA-2 and IA-2{beta} compared to wild type mice (876 ± 113, 962 ± 130, and 596 ± 82 vs. 1367 ± 93; p <0.01, p<0.02 and p< 0.001). Renin mRNA levels were reduced to 26.4 ± 5.1%, 39 ± 5.4%, and 35.3 ± 5.5% of wild type in IA-2-/-, IA-2{beta}-/-, and IA2/IA-2{beta}-/- mice. Plasma aldosterone levels were not significantly different between genotypes. The regulation of PRC by furosemide and salt intake, and of aldosterone by salt intake was maintained in all genotypes. IA-2 and IA-2{beta} expression did not co-localize with renin, but showed overlapping immunoreactivity with tyrosine hydroxylase. While propranolol reduced PRC in wild type mice, it had no effect on PRC in IA-2/ IA-2{beta}-/- mice. Renal tyrosine hydroxylase mRNA and immunoreactivity was reduced in IA-2/ IA-2{beta}-/- mice. We conclude that IA-2 and IA-2{beta} are required to maintain normal levels of renin expression and renin release, most likely by permitting normal rates of catecholamine release from sympathetic nerve terminals.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.